<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 41 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page40.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=41">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 41 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 41</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=41"><img src="../thumb/41.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>10 / 2020-04                                                  Central Nervous System - 1.3.2 / 1.4 / 1.4.1
   Indications: Anx.disords.with/without accomp. depress.  Special precautions: Childr.as relat.small overdos. fatal, CV dis-  (S5) TABS, B1536, 1537.
   (S5) TABS. 30/2.6.5/0168.    ords./dis., narr.angle glauc., micturit. disords., low.convuls.thresh.&   771120-001: 10 mg, 100, R226,49
   825719-003: 10 mg, 60, R377,29  predispos. fact., sev.hepat./ren.dis., tumours of adren.medul., con-  771139-004: 25 mg, 100, R408,71
   Dosage: Init: 5 mg 2-3x/day incr.in 5 mg increm. at 2-3 day in-  com. electro convuls.ther., elderly, adolesc., constipat., incr.IOP,   Dosage: Ambul.pts: Indiv. Init.25-75 mg/day, upto 150-200 mg/
   terv. Usual.effect.dly.dos: 20-30 mg dly.in div.dos. Incr.as necess.to   hyperthyroid., suicid.tendenc., if depress.turns.into man.phase,   day. Maint: 50-100 mg dly.
   max.60 mg/day in div.dos.    diabet., discont.as early as poss.prior to elect.surg., reduc.dos.of   Hospital.pts: Sev.cases: Optim.dos.betw.200-300 mg dly.slow.
   Contraindications: Pregn., lact., sev.ren./ hepat.impairm., seiz.dis-  concom. oestrog.  reduc.to indiv.maint.dos.usual. 100 mg dly.
   ords., safety & effic.in childr.und.18 yrs.not est., MAOI.  Drug interactions: Respons.to other CNS depress. incl.alcoh.&   Noct.enures: Childr: Admin.as sngl.dos.aft. even. meal. 5-8 yrs:
   Side effects: Dizzin., naus., headache, nervousn., light-headedn.,   anticholinerg.potent., barbit. & other enzyme induc.low.plasma   20-30 mg dly. 9-12 yrs: 25-50 mg dly. Old.childr: 25-75 mg dly. Cont.
   excitem., paraesthes., sleep disturbs., chest pain, tinnit., nas.con-  conc., cimetid./ methylphenid./CCB’s & neurolept.incr.plasma conc.,   with success.reduc.maint.dos.for further 1-3 mnths.
   gest., hypersens. reacts.    antihypertens.effs.of bethanidine/ desbrisoquine/ guanethidine &   Geriatr: Init: 10 mg/day. Maint: 30-50 mg/day.
   Special precautions: Mod.hepat./ren.impairm., discont.use of   poss.clonidine reduc., CV effs.of noradren/adrenal.& nas.drps.&   Contraindications: Ac.MI phase, MAOI, porphyr., lactat., pregn.,
   benzodiazepin.& other sedat./ hypnot.meds.grad.prior to treatm.,   loc. anaesth.contain sympathomimet.poss potent., halofantrine &   concom.quinidine type anti-arrhythm.
   cont.lact.                   antiarrhythm.prolong.QT interv. poss. incr.ventric.arrhythm.risk, as-  Side effects: Anticholinerg.effs.,CNS/CV effs., allerg.alveolit., GI
   Drug interactions: Benzodiazepin., haloperidol & chlordiazepoxide.  temizole/ terfenadine/ cisapride & sotalol may incr.arrhythm. risk.,   disturbs., skin rash, weight gain/loss, libido disturbs., enlarg.breasts,
   Warnings: May low.convuls.thresh., do not admin. with alcoh.  ster.hormon.inhib.metab., plasma conc.of high. prot.bound meds.(e.g.   galactorrh., SIADH, incr./decr.bld.sugar, bld. dyscras., withdr.sympt.
                                warfar.& digox.) incr.& poss. adverse.reacts.result.from displacem.of
   PHARMA-Q HYDROXYZINE INJECTION 100 mg/2 ml,   prot. bound clomipram.  follow.abrupt.discont.
                                                              Special precautions: Manias, mictur.disords., low convuls.thresh.,
   Pharma-Q [P/S]                                             CV insuffic., AV block (grades I-III), arrhythm., hyperthryoid., concom.
   Hydroxyzine                  ETHIPRAMINE, (Aspen Pharmacare: Pharma) Pharmacare [P/S]  thyroid treatm., sev.hepat./ren.dis., suicid. tendenc., surg., narr.angle
   Indications: Pre-& post-op sedat., N&V, symptomat. treatm.of ver-  Imipramine HCl.  glauc., adren.medulla tumours, concom.electroconvuls.ther., in childr.
   tigo/Meniere’s dis.& relat.disords.  Indications: Endog.depress., Parkinson., chron. alcoh., child be-  do not exceed dly.dos.of 2,5 mg/kg, orthostat. hypotens., incr.dent.
   (S5) INJ, 31/2.6.3/0070. 100 mg/2 ml  hav.disords.         caries incid.with prolong. treatm.
   703584-001: 10x2 ml, R56,07  (S5) TABS. B695, 694.         Drug interactions: Pressor eff.of adrenal.& nor adrenal.enhanc., an-
   Dosage: Admin.deep IM only.  724661-107: 10 mg, 100, R56,98  tihypertens.eff.of adrenerg. neurone inhibit.decr., mutual potent.of eff.
   Adults: 25-100 mg. Childr: 1,1 mg/kg bm.  724661-115: 10 mg, 1 000, R569,85  with anticholinerg., subst.activat.hepat.mono-oxygen enzyme syst.re-
   Contraindications: IV use, prem.infts./neonates, piperazine deri-  724688-102: 25 mg, 100, R67,23  duc.antidepress.eff., neurolept.& cimetidine incr.plasma conc., incr.ser.
   vate.hypersens., porphyr., safety in pregn.& lactat.not est., not for   724688-110: 25 mg, 1 000, R672,31  phenytoin conc., other CNS depress.incr.CNS depress.eff., methylpheni-
   control of bld.transfus.react.caus.by ABO incompatibil.  Dosage: Adults: 75-150 mg dly.in div.dos.or as prescr. Elderly:   date incr.plasma conc., steroid hormon. inhibit metabol., decr.alcoh.tol.
   Side effects: Drowsin.,dizzin., paradox.CNS stimulat. esp.in childr.,   Max. 10-30 mg dly. Childr: 6-12 yrs: 25 mg at bedt. Over 12 yrs:
                                50 mg at bedt.
   dry mouth, thicken.resp. tract secret., tightn.of chest., blurr.vis., urin.  TREPILINE, (Aspen Pharmacare: Pharma) Pharmacare [P/S]
   diffic. /retent., GI disturbs.incl.incr.gastr.reflux., trans. bradycard.fol.  Contraindications: Ac.phase MI, pregn.unless compell.reasons.  Amitriptyline.
                                Side effects: Dry mouth, constip., urin.retent., pupil dilat.with blurr.
   by tachycard. with palpitat.& arrhythm. in high dos., CNS stimulat.  vis.& vis.accommod.chang., drowsin., excess sedat., disorient., agi-  Indications: Depress.in pts ≥ 18yrs.
   in high dos., bld. disords., hypotens., tinnit., headache, paraesthes.  tat., insomn., restlessn.  (S5) TABS. J/1.2/219, 220.
   Special precautions: Decr.dos,in prim.bil. cirrhos., clos.angl.glauc.,   Special precautions: Manic depress.psychos., prostatism, CV dis.,   772003-009: 10 mg, 100, R117,70
   urin.retent., prostat. hypertroph., pyloroduoden.obstruct., epilep., sev.   glauc., epilep., 1st trimest. pregn., cont.sucr.  772003-017: 10 mg, 500, R588,50
   CV disords., may mask warn.signs of damage caus. by ototox.agents.  Drug interactions: Alcoh.& CNS depress.incr. CNS depress.risk,   771996-004: 25 mg, 100, R120,16
   Drug interactions: CNS depress.activ.poss. aggrav. by intake of   anticholin.drugs., MAOI, adren., press.effs.of nor-adren.enhanc., hy-  771996-012: 25 mg, 500, R600,78
   alcoh./barbitur./hypnot./opioid analges./ anxiolyt.sedat. & neuro-  potens.eff.of cert.antihypertens.reduc.  Dosage: Init. 75-150 mg dly in div.doses. Maint. 50-100 mg dly
   lept., MAOI may enhanc. antimuscarin. effs., addit.antimuscarin.   in div.doses.
   act. with atrop.& TCA’s.     SANDOZ AMITRIPTYLINE HCl 25, Sandoz [P/S]  Contraindications: MI, hist. of MI/dysrhythm./ CHF/ coron.artery
   RESTIN, AI Pharm Ltd [P/S]   Amitriptyline HCl.            insuffic., MAOI, concurr. linezolid/ antihypertens. meds., pregn.&
                                Indications: Endogen.depress., adjunct.therapy for nocturn.enures
   Valerian powder 50 mg, Vit.B1 0,80 mg, B6 1,20 mg, B12 0,95 µg, Vit.C   in childr.over 11 yrs.once organ. pathol.has been exclud.  lactat., childr. &lt; 18 yrs., mania, sev.liv.dis.
                                                              Side effects: Freq: Drowsin./excess.sedat., blurr. vis., accommodat.
   48 mg, nicotinamide 4 mg, Ca pantothenate 0,40 mg.  (S5) TABS, W/1.2/60
   Indications: Non-psychot.restlessn.& tens. states.  784230-005: 25 mg, 100, R82,95  disturb., incr.IOP, dry mouth, constip., urin.retent., hypertherm. Less
                                                              freq: Bone marr. depress.incl.agranulocytos./ eosinophil./ leucopaen./
   (S1) CAPS. U/2.6/218.        784230-013: 25 mg, 500, R372,55
   760226-008: 30, R35,49       Dosage: Depress: Adults: 25 mg 3xdly. If necess.incr.grad.by in-  thrombocytopaen./ purpura, hypersens.reacts. incl.photosens./ oed.
   Dosage: Adults:1-2 caps. 3xdly.as reqd. Childr: 1 cap.3xdly.as reqd.  crem.of 25 mg to max. 150 mg/day. Maint: 25 mg 2-4xdly. Elderly:   of face& tong./angioed., syndr.of inappropr.ADH secret., hypergly-
   Side effects: Dizzin., depress., skin reacts., gastr.intol., incr.perspirat.  50 mg/day as sngl./div.dos.  caem., hypoglycaem., hyponatraem., incr.appet., weight gain/loss,
                                                              anorex., confus.states, disorient., agitat., insomn., nightmar., delus.,
   STRESAM, AI Pharm Ltd [P/S] &  Enures.adjunct: 11-16 yrs: 25-50 mg.at bedt  hallucin., mania/ hypomania, excitem., anx., restlessn., disturb. con-
                                Contraindications: Ac.MI phase, liv.damage, urin.retent., CF , re-
   Etifoxine HCl.                                             centrat., behav.chang., suicid.ideat./behav., dizzin., headache, periph.
   Indications: Anx.psychomat.manifestat.  cent infarct., ischaem.heart dis., MAOI.  neuropathy, numbn., tingl.& paraesthes.of extremit., incoordinat.,
                                Side effects: Dry mouth, constip., urin.retent., vis. disturbs., palpit.,
   (S5) CAPS. A39/2.6/0072                                    atax., trem., coma, epileptif.seiz., alter.EEG, extra-pyramid.sympts.incl.
   707127-002: 50 mg, 100, R429,97  tachycard., N&V, CNS eff., orthostat. hypotens., hypertens., hypo-  abnorm.invol. movements & tard.dyskines., dysarthr., mydrias., tinnit.,
                                man., epileptiform seiz., skin reacts., libido chang., impot., gynaeco-
   Dosage: Treatm.durat.of few days to few wks. not exceed.8 wks.  mast., galactorrh., extrapyramid sympts., mass loss/gain, jaund., bld.  palpitat., tachycard., MI, heart block, non-specif.ECG chang.& chang.
   150-200 mg/day in 2-3 div.dos.  disords., conduct.disturbs.  in AV-conduct., dysrhythm., hypotens., syncope, postur. hypotens., hy-
   Contraindications: Shock, sev.imp.liv/ren. funct., myasthen.  Special precautions: Elderly, prostat. hypertrophy, depress.phase   pertens., stroke, N&V, diarrh., paralyt. ileus, epigastr.distr., dysgeus.,
   grav., galactosaem/gluc.& galact. malabsorpt.syndr. or lactase   of manic depress., psychos., epilep., glauc., schizophren., suicid. ten-  stomatit., metall. taste, parotid swell., black tong., hepatit., skin rash,
   defic.due to lactose pres, in absenc.of clinic.data not recomm. in   denc., diabet., hyperthyroid., discont.bef.elect. surg., pregn.& lactat.  alopec., urin.freq., urin.tract dilat., gynaecomast., breast enlargem.,
   pregn.& breast feed.         Drug interactions: Press.eff.of dir.act. sympathomimet. enhanc.,   galactorrh., testicul. swell., libido chang., impot., sex. dysfunct.,
   Side effects: Init.drowsin., skin reacts., urticar., angio-oed., metor-  hypotens.eff.of cert. antihypertens. reduc., thyroid preps.enhanc.  weakn., fatig., incr.sweat. Freq. unknown: Incr. risk of bone fract.
   rhag.with concom.OC’s        eff., concom. anticholinerg.poss.danger., hypertens. cris. with MAOI’s,   Warnings and special precautions: Small dos. poss.fatal in childr.,
   Warnings and special precautions: Cross. placent. barr., dis-  inhibit.of P450 isoenzyme CYP2D6 incr.plasma conc. & enzyme in-  discont.if anticholinerg. effs. sev., excess.sedat.in cert.pts., card.dis.,
   cont.in event of skin or allerg. reacts./sev.hepat.disords., safety in   duc.reduc. respons.  reg. cardiologic. & electrocardiograph. examin.advis., endocr. effs.,
   porphyr.not est.                                           depress.phase of manic depress.as mania poss.precipitat., pts.with
   Drug interactions: CNS depress.& alcoh.incr. sedat.eff.  THADEN, (Aspen Pharmacare: Pharma) Pharmacare [P/S]  suicid.tendenc., hypotens. eff.of cert.antihypertens.agents poss. reduc.,
   See also MDR page 108.       Dothiepin HCl.                pressor eff.of epinephrine/norepinephrine enhanc., avoid loc.anaesth.
                                Indications: Adult depress.   contain.epinephrine/ norepinephrine as hypertens.reacts.poss., por-
                                (S5) CAPS, [P/S] Z/1.2/171.   phyr., hyperthyroid., imp.liv.funct., epilep., untreat. narrow-angle glauc.,
   1.4    Anti-depressants      800198-018: 25 mg, 100, R164,54  urin.retent., prostat. hypertrophy, constip., discont.if allerg. skin reacts.
                                (S5) TABS, [P/S] Z/1.2/301.
                                                              occur., elderly, inadvis.with electro convuls.ther., consid.hyponatraem.
                                800201-019: 75 mg, 28, R150,40  in pts.develop. drowsin./ confus./convuls., may impact glycaem. contr.
   1.4.1  Tricyclic             Dosage: Indiv. Init. 25 mg 3xdly.grad.incr.to 50 mg 3xdly.if necess.   of pts.with diabet.mellit., lact.intol., concom. reboxitine, monit.for incr.
                                OR 75 mg or 150 mg as sngl.night time dos. Elderly: Init.50-75 mg
                                                              antidepress. plasma lev.& toxicit.with concom.fluoxetine, avoid con-
                                dly. Half norm.maint.dos.     com.apraclonidine/ brimonidine/ pimozide/ thioridazine/entacapone
   CLOMIDEP, Ranbaxy [P/S]      Sev.depress.pts: up to 225 mg dly.has been given.  Interactions: Eff.poss.potent.by MAOI, reduc. eff. of cert.antihyper-
   Clomipramine HCl.            Contraindications: Ac.MI phase, heart block, 1st trimest.pregn.  tens.agents., incr.hypertens. risk on clonidine withdraw., incr.plasma
   Indications: Maj.depress., react.depress., second. depress  Side effects: Dry mouth, metall.taste, urin. retent., blurr.vis., ac-  conc. with cert. SSRIs, incr.risk of CNS toxic.with tramadol, incr.sedat.
   (S5) TABS. 35/1.2/0253       comodat.disturbs., palpitat., tachycard., impot., CNS eff., periph.  with opioid analges., incr. risk of dysrhythm./hypotens.with concom.
   703381-001: 25 mg, 50, R190,03  neuropathy, orthostat. hypotens., hypertens., sweat., atax., epilep-  anaesth., incr.risk of ventric.dysrhythm.with meds. prolong.QT interv.
   Dosage: Indiv.init.at low.recomm.dos.incr.grad.  tiform seiz., extrapyramid.sympts., GI disturbs., allerg.skin reacts.,   incl. amiodarone/ disopyramide/procainamide/propafenone/ quini-
   Adults: Init. 25 mg 2-3xdly grad.incr.by 25 mg increm.at 3-4 day   photosensitisat., cholest. jaund., bld.disords., poss.conduct. defects   dine, plasma conc.poss.reduc.by rifampicin, CNS excitat.& hypertens.
   interv.to tot.dly.dos.of 150 mg. OR init.with sngl.dos.of 50-100 mg   & card.arrythm., endocrine eff.  with linezolid, incr.risk hypertens.& dysrhythm.with concom. sympa-
                                Special precautions: Elderly, depress.phase of manic depress.
   at bedt.incr.by 25-50 mg to tot.dly dos.of 150 mg. Maint: Usual. 50-  thomimet. agents, metabol.poss.inhib.by methylphenidate/disulfiram,
   100 mg dly. contin.x3 mnths.bef.grad.withdr. Max.dly dos: 250 mg.  psychos., prostatism, card.dis., poss.aggrav.epilep.& untreat.narr.  enhanc.eff.of alcoh./ barbits.& CNS.depress., concom.use with an-
                                angle glauc., hyperthyroid., diab., 25 mg cont.lact., 75 mg sugar free.
   Elderly: Init.10 mg dly, incr.to 30-50 mg dly.  Drug interactions: CNS depress., MAOI’s/within 14 days of stop.  tiepilept. meds.may low.convuls.thresh., decr. antidepress. act.with
   Contraindications: Sev.liv.dis., heart block, card. arrhythm., immed.  treatm., press.eff.of direct act. sympathomimet.enhanc., concom.  barbit./carbamazepine, incr. ser.conc.with fluconazole/ritonavir, incr.
   recov.period aft.MI, safety in pregn.& lactat.not est., MAOI’s, concom.  anti-cholinerg. poss.dangerous, hypotens.eff.of cert. antihypertens.   anticholinerg. & sedat.eff.with antihistamin., incr. plasma conc with
   anti-arrhythm. of quinidine type.  poss.reduc., eff.of TCA’s influenc. by agents aff.their metabol., hy-  antipsychot.meds./ diltiazem/ verapamil, incr.ventric.dysrhythm.risk
   Side effects: GI disturbs., CNS/psych.& neurol. effs., genitourin.  perthyroid pts./ those tak.thyroid preps.may have enhanc.respons.,   with sotalol/antipsychot.meds., incr.postur. hypotens.with diurets.,
   complaints incl.libido changes, vis. disturbs., incr.IOP, hypertherm.,   eff. of bethanidine, debrisoquine, guanethid.& poss. clonidine reduc.  CNS toxic.with selegiline, musc. relax.eff.of baclofen incr., eff.of
   CV effs.incl. arrhythm., bld.dyscras., weight loss, galactorrh., breast   subling. nitrates reduc., OCs antag.antidepress.eff.& incr. plasma
   enlargem., inappropr.antidiuret.hormone secret.syndr., gynaeco-  TOFRANIL, Pharmaco [P/S]  conc., eff.of concom. anticholinerg. agents incr., hepat.metabol.reduc.
   mast., bld.sugar.lev. changes, menstr.irregular., testic.enlargem.,   Imipramine HCl.  by cimetidine, decr. plasma lev.with St. John’s Wort, conc.of thiori-
   allerg. reacts.              Indications: Depress., noct.enures.from 5 yrs.  dazine incr., accelerat.respon.to Trepiline by concom.thyroid preps.</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page40.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page36.html">36</a>&nbsp;&nbsp;&nbsp;<a href="page37.html">37</a>&nbsp;&nbsp;&nbsp;<a href="page38.html">38</a>&nbsp;&nbsp;&nbsp;<a href="page39.html">39</a>&nbsp;&nbsp;&nbsp;<a href="page40.html">40</a>&nbsp;&nbsp;&nbsp;<a href="page41.html">41</a>&nbsp;&nbsp;&nbsp;<a href="page42.html">42</a>&nbsp;&nbsp;&nbsp;<a href="page43.html">43</a>&nbsp;&nbsp;&nbsp;<a href="page44.html">44</a>&nbsp;&nbsp;&nbsp;<a href="page45.html">45</a>&nbsp;&nbsp;&nbsp;<a href="page46.html">46</a>
             </td>
             <td width="35%"><a href="page42.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page42.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
